Oncology / Cancer Collection home page

Browse
Subscribe to this collection to receive daily e-mail notification of new additions RSS Feed RSS Feed RSS Feed
Collection's Items (Sorted by Submit Date in Descending order): 1 to 20 of 54
 next >
YearTitleAuthor(s)
Jan-2013Immunoglobulin G subclass deficiency and infection risk in 150 patients with chronic lymphocytic leukemiaForsyth, Cecily J; Freeman, J. A.; Crassini, K. R.; Best, O. G.; Mackinlay, N. J.; Han, P.; Stevenson, W.; Mulligan, S. P.
Aug-2016Correlation of blood counts with vascular complications in essential thrombocythemia: analysis of the prospective PT1 cohortForsyth, Cecily J; Campbell, P. J.; MacLean, C.; Beer, P. A.; Buck, G.; Wheatley, K.; Kiladjian, J. J.; Harrison, C. N.; Green, A. R.
Oct-2018Optimising Outcomes for Glioblastoma through Subspecialisation in a Regional Cancer CentreBack, Michael F; Jayamanne, Dasantha; Wong, Mathew H; Cove, N; Wheeler, H; Khasraw, M; Guo, L; Back, J
Sep-2018Understanding the Revised Fourth Edition of the World Health Organization Classification of Tumours of the Central Nervous System (2016) for Clinical Decision-making: A Guide for Oncologists Managing Patients with GliomaMichael, Michael F; Jayamanne, Dasantha; Rodriguez, M; Khasraw, M; Lee, A; Wheeler, H
Nov-2018Recommendations for the use of pegylated interferon-alpha in the treatment of classical myeloproliferative neoplasmsForsyth, Cecily J; Chan, Wai-Hoong; Grigg, A.P.; Cook, N.C.; Lane, S.W.; Burbury, K.L.; Perkins, A.C.; Ross, D.M.
Jan-2014Cognitive Deficits in Primary Brain Tumours: A Framework for Management and RehabilitationBack, Michael F; Back, E.; Wheeler, H.; Kastelan, M.
Dec-2013Dosimetric Improvements Utilising Intensity Modulated Radiation Therapy for Patients with Glioblastoma MultiformeBack, Michael F; Eade, Thomas; Clifford, S.; Wheeler, H.
Jul-2017Survival Outcomes of Elderly Patients With Glioblastoma Multiforme in Their 75th Year or Older Treated With Adjuvant TherapyBack, Michael F; Jayamanne, Dasantha; Harris, G.; Wheeler, H.; Gzell, C.; Kastelan, M.; Schembri, G.; Brazier, D.; Cook, R.; Parkinson, J.; Khasraw, M.; Louw, S.
Mar-2017Short-Course Radiation plus Temozolomide in Elderly Patients with GlioblastomaBack, Michael F; Perry, J. R.; Laperriere, N.; O'Callaghan, C. J.; Brandes, A. A.; Menten, J.; Phillips, C.; Fay, M.; Nishikawa, R.; Cairncross, J. G.; Roa, W.; Osoba, D.; Rossiter, J. P.; Sahgal, A.; Hirte, H.; Laigle-Donadey, F.; Franceschi, E.; Chinot, O.; Golfinopoulos, V.; Fariselli, L.; Wick, A.; Feuvret, L.; Tills, M.; Winch, C.; Baumert, B. G.; Wick, W.; Ding, K.; Mason, W. P.
Jul-2018Utilizing 18F-fluoroethyltyrosine (FET) positron emission tomography (PET) to define suspected nonenhancing tumor for radiation therapy planning of glioblastomaJayamanne, Dasantha; Back, Michael F; Kaushal, Sneha; Hayes, A. R.; Hsiao, E.; Schembri, G. P.; Bailey, D. L.; Roach, P. J.; Khasraw, M.; Newey, A.; Wheeler, H. R.
Feb-2018Utilizing 18F-fluoroethyl-l-tyrosine positron emission tomography in high grade glioma for radiation treatment planning in patients with contraindications to MRIJayamanne, Dasantha; Back, Michael F; Chan, D.; Schembri, G.; Brazier, D.; Bailey, D.; Wheeler, H.
Nov-2016Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup studyBack, Michael F; Reijneveld, J. C.; Taphoorn, M. J.; Coens, C.; Bromberg, J. E.; Mason, W. P.; Hoang-Xuan, K.; Ryan, G.; Hassel, M. B.; Enting, R. H.; Brandes, A. A.; Wick, A.; Chinot, O.; Reni, M.; Kantor, G.; Thiessen, B.; Klein, M.; Verger, E.; Borchers, C.; Hau, P.; Smits, A.; Golfinopoulos, V.; Gorlia, T.; Bottomley, A.; Stupp, R.; Baumert, B. G.
Jun-2018Convergent priorities and tensions: a qualitative study of the integration of complementary and alternative therapies with conventional cancer treatmentBack, Michael F; McKenzie, H.; Levy, D.; Pavlakis, N.; Oh, B.
Mar-2018Survival improvements with adjuvant therapy in patients with glioblastomaJayamanne, Dasantha; Back, Michael F; Wheeler, H.; Cook, R.; Teo, C.; Brazier, D.; Schembri, G.; Kastelan, M.; Guo, L.
Sep-2016Oxidative stress in prostate cancer patients: A systematic review of case control studiesBack, Michael F; Eade, Thomas; Oh, B.; Figtree, G.; Costa, D.; Hruby, G.; Lim, S.; Elfiky, A.; Martine, N.; Rosenthal, D.; Clarke, S.
Apr-2017Factors affecting whether or not cancer patients consider using acupunctureBack, Michael F; Eade, Thomas; Oh, B.; Kneebone, A.; Pavlakis, N.; Clarke, S.; Eslick, G.; River, J.
May-2016Cilengitide with metronomic temozolomide, procarbazine, and standard radiotherapy in patients with glioblastoma and unmethylated MGMT gene promoter in ExCentric, an open-label phase II trialBack, Michael F; Khasraw, M.; Lee, A.; McCowatt, S.; Kerestes, Z.; Buyse, M.; Kichenadasse, G.; Ackland, S.; Wheeler, H.
May-2016Small increases in enhancement on MRI may predict survival post radiotherapy in patients with glioblastomaBack, Michael F; Gzell, C.; Wheeler, H.; McCloud, P.; Kastelan, M.
Mar-2016Proliferation Index Predicts Survival after Second Craniotomy within 6 Months of Adjuvant Radiotherapy for High-grade GliomaBack, Michael F; Gzell, C.; Wheeler, H.; Huang, D.; Gaur, P.; Chen, J.; Kastelan, M.
Mar-2015Large volume re-irradiation with bevacizumab is a feasible salvage option for patients with refractory high-grade gliomaBack, Michael F; Gzell, C.; Kastelan, M.; Guo, L.; Wheeler, H.
Collection's Items (Sorted by Submit Date in Descending order): 1 to 20 of 54
 next >